Ocrelizumab, which is sometimes called an Ocrevus injection, is an intravenous injection used to treat various types of multiple sclerosis, such as clinically isolated syndrome, active secondary progressive disease, relapsing-remitting MS (RRMS), and primary progressive multiple sclerosis (PPMS)
When combined with BPC-157, they form a powerful regenerative protocol
But none of us should settle for inadequate rest, because our health takes a hit: Poor sleep is associated with increased risk of coronary heart disease, osteoporosis, and decreased cognitive function, as well as overall mortality
Lyophilised BPC-157 should be stored at 20 C (2 to 3 years), at 2 to 8 C 6 to 12 months, room temperature up to 30 days
Its also known to improve bone density and enhance sleep quality, making it a popular choice for comprehensive rejuvenation